Immunogen (NASDAQ:IMGN) reported its Q4 earnings results on Friday, February 25, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Immunogen reported an EPS of $-0.17.
Revenue was up $57.81 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 1.86% increase in the share price the next day.
Here's a look at Immunogen's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.18 | -0.18 | -0.19 | -0.08 |
| EPS Actual | -0.18 | -0.15 | -0.17 | 0.16 |
| Revenue Estimate | 19.03M | 18.92M | 17.73M | 40.83M |
| Revenue Actual | 9.21M | 16.95M | 15.71M | 85.80M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
